shouldiuse.io

Categories

VERDICT

Solidus — Life Sciences Deal Intelligence & Benchmarks Review

Depends

Should I use Solidus — Life Sciences Deal Intelligence & Benchmarks?

Instant deal benchmarks, rNPV analysis, and Monte Carlo simulation for biopharma licensing, M&A, and pharma partnerships. 2,300+ verified transactions across 12 therapeutic areas and 23+ modalities. Upfront payments, milestones, royalty rates, partner matching, and AI deal memos — powered by SEC EDGAR, FTC pre-merger filings, and ClinicalTrials.gov data. Free to start. - calculator.ambrosiaventures.co

· 1 month ago

Try the free tier if you run biopharma BD or licensing and need quick deal comparables; pay the $2,500 Concierge only after a demo proves the data depth. Confidence is low — no independent reviews exist, so big pharma should benchmark it against Cortellis or Evaluate first.

Confidence

Low. Based on 3 usable public sources (product site, security page, one Reddit category thread). Most search results concerned unrelated companies named 'Solidus' — Solidus Labs (crypto compliance), Solidus ecommerce (nebulab), Solidus AI Tech, and Solidus Bio. No independent reviews of this product were found.

Ratings

  • Value for money
  • Ease of useNo user feedback found.
  • Feature depth
  • Support qualityNo evidence.
  • Security posture

Pricing

$0

Free

ModelNot disclosed
Monthly feesNot disclosed
HardwareNot disclosed
Free tierYes
Pro / ReportNot published
Concierge$2,500 one-time

Best for

  • Biopharma BD and licensing teams
  • Early-stage biotechs pricing partnerships
  • Life sciences M&A analysts
  • Teams needing fast deal comparables

Not for

  • Big pharma BD teams needing deep, audited deal data
  • Anyone outside biopharma licensing, M&A, or partnerships
  • Buyers who require independent reviews before paying
  • Solo researchers — free calculators or spreadsheets suffice

Gotchas - check before you buy

medium

Pro and Report tier prices undisclosed; only Concierge $2,500 is public.

medium

Free-tier limits (calculations, saved reports) not disclosed anywhere.

medium

Vendor's own deal counts disagree — verify database size in a demo.

low

Security is self-reported; vendors (Vercel, Supabase) are SOC 2, product untested.

Pros and cons

Pros

  • Free tier exposes 1,400+ verified deals with ~30-second results
  • rNPV, Monte Carlo, and AI deal memos in one tool
  • Covers 12 therapeutic areas and 23+ modalities
  • Data pulls from SEC EDGAR, FTC filings,
  • Granular published security controls: RLS, PKCE, encryption, rate limits

Cons

  • Deal-count claims conflict: 1,400+ vs 2,300+ across pages
  • Zero named customers or case studies on the site
  • Pro/Report tier pricing not published
  • Security posture self-reported; no third-party audit shown
  • Name collides with unrelated Solidus products, muddying research

Sources & method

- 3 sources - No known vulnerabilities found in the sources reviewed. Self-reported posture: TLS 1.2+, AES-256 at rest, RLS, PKCE auth, Stripe PCI DSS Level 1; no third-party audit of the product itself.

official x1review x1security x1

Key stats

  • Value for money: 4/5

    Rating

  • $0

    Starting price

  • 3

    Sources

  • Analyzed

  • Value for money: 4/5. Free tier; $2,500 one-time undercuts enterprise suites.
  • Ease of use. No user feedback found.
  • Feature depth: 4/5. rNPV, Monte Carlo, 1,400+ deals, AI memos.
  • Support quality. No evidence.
  • Security posture: 4/5. Strong documented controls, but self-reported only.
  • $0 Starting price Free tier with 1,400+ deal benchmarks
  • Yes Free tier Vendor claims results in ~30 seconds
  • 1,400–2,300+ Deal database Counts conflict between homepage and tagline
  • 12 TAs, 23+ modalities Coverage Per vendor marketing

Pricing

Free

$0

  • 1,400+ verified deal benchmarks
  • Results in ~30 seconds
  • Usage limits undisclosed

Pro / Report

Not published

  • Tiers exist per security docs
  • Prices and features unpublished

Concierge

$2,500 one-time

  • Intelligence Brief
  • Maps full landscape, all modalities

Security

No known vulnerabilities found in the sources reviewed.

Self-reported posture: TLS 1.2+, AES-256 at rest, RLS, PKCE auth, Stripe PCI DSS Level 1; no third-party audit of the product itself.

What users say

No independent user reviews of Solidus surfaced in the sources reviewed; Reddit discussion covers rival pharma intelligence platforms.

Alternatives

Compare Solidus — Life Sciences Deal Intelligence & Benchmarks with each alternative.

  • Excel + SEC EDGAR (DIY)

    Free DIY valuation modeling; slower but fine for occasional deals.

Full analysis

Based on 3 usable public sources (product site, security page, one Reddit category thread). Most search results concerned unrelated companies named 'Solidus' — Solidus Labs (crypto compliance), Solidus ecommerce (nebulab), Solidus AI Tech, and Solidus Bio. No independent reviews of this product were found.

Free tier makes it a cheap test for biopharma deal benchmarking; no independent reviews — vet before paying $2,500.

Methodology

Based on 3 usable public sources (product site, security page, one Reddit category thread). Most search results concerned unrelated companies named 'Solidus' — Solidus Labs (crypto compliance), Solidus ecommerce (nebulab), Solidus AI Tech, and Solidus Bio. No independent reviews of this product were found.

Read how a report is made.

Sources

  1. official
  2. Product security page — Ambrosia Venturescalculator.ambrosiaventures.co
    security
  3. review

Add this review to your site

This check for Solidus — Life Sciences Deal Intelligence & Benchmarks says Depends.

Put the badge on your site.

Visitors see the independent review.

The link points here, and search engines follow it.

This is the badge visitors see on your site.

Paste one snippet. Keep the link as it is. A nofollow tag stops search engines from following it.

Rate this review

Anonymous. You can change your vote.

Loading votes…

Comments

One queue. No nested comments. Give a display name first. Limit: 200 words per comment. You can edit or delete yours.

Save a name to write a comment.

0 / 200 words

No comments yet.